Skip to content

use of different treatment techniques on same patient to reduce gum infection of patient undergoing orthodontic treatment

â??Comparative evaluation of the efficacy of chlorhexidine,diode LASER and photodynamic therapy as an adjunct to scaling and root planing in the treatment of gingival inflammation and enlargement in orthodontic patients â?? A split mouth randomized trialâ??â??

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/012191
Enrollment
20
Registered
2018-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- gingival enlargement and gingival inflammation in orthodontic patients

Interventions

Intervention1: chlorhexidine,LASER,indocyanin green: 0.2%chlorhexidine,photodynamic therapy using indocyanin green,LASER(810 nm) Intervention2: Chlorhexidine: 0.2% Chlorhexidine Digluconate Interventi

Sponsors

Sreedevi K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients aged between 14-27 yrs. 2.Patient undergoing orthodontic treatment and referred to The Department of Periodontics for gingival inflammation and enlargement in all 4 quadrants. 3.Patients without any systemic illness. 4.Patients without any history of known drug allergy especially to indocyanin green 5.Nonsmokers. 6.Patient who has gingival overgrowth index >=1 for each quadrant.

Exclusion criteria

Exclusion criteria: 1.Patients who are taking medications that may cause drug-associated gingival enlargement, e.g. calcium channel blockers, anticonvulsants or immunosuppressant. 2.Patients with lingual orthodontic appliance. 3.Pregnant or lactating women. 4.Women patients on any hormonal therapy. 5.Patients who are not competent in giving consents. 6.Patients who has undergone for periodontal surgery and do not follow proper oral hygiene practice.

Design outcomes

Primary

MeasureTime frame
EXPECTING REDUCTION IN GINGIVAL ENLARGEMENT OR GINGIVAL INFLAMMATIONTimepoint: BASELINE,3 MONTHS,6 MONTHS

Secondary

MeasureTime frame
gradual reduction in gingival inflammation and enlargementTimepoint: 3months,6months

Countries

India

Contacts

Public ContactAnnaji sreedhara

Coorg Institute of Dental Sciences

sreedevikeeneri@gmail.com9400481001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026